Trimethoprim-sulphamethoxazole in acute osteomyelitis due to penicillin-resistant staphylococci in Uganda.

British medical journal ·Vol. 3 ·No. 5716 ·1970-07-25 ·Pages 201-3

Craven JL, Pugsley DJ, Blowers R

Abstract

Most recent cases of staphylococcal osteomyelitis seen at Mulago Hospital, Kampala, have been due to penicillin-resistant organisms. Six severely ill patients-four with multiple bone lesions-were treated with trimethoprim-sulphamethoxazole; the response was prompt and satisfactory in all cases.

MeSH Terms

Acute Disease Adolescent Child Child, Preschool Drug Synergism Female Folic Acid Antagonists/therapeutic use Humans Male Osteomyelitis/drug therapy Penicillin Resistance Pyrimidines/therapeutic use Staphylococcal Infections/drug therapy Sulfamethoxazole/therapeutic use Uganda

Chemicals

Folic Acid Antagonists Pyrimidines Sulfamethoxazole

Authors & Affiliations

3 authors, click to expand affiliations / ORCID

Craven J L

Pugsley D J

Blowers R

References (2)

2 references, click to expand

Trimethoprim: laboratory and clinical studies.
J Clin Pathol. 1968 Mar;21(2):202-9 PMID: 5697054
Combined treatment with antibacterial chemotherapeutical agents in staphylococcal infections.
Q J Med. 1969 Jan;38(149):91-106 PMID: 5190628

Article Info

Journal

British medical journal

Abbr.

Br Med J

ISSN

0007-1447

DOI

10.1136/bmj.3.5716.201

Published

1970-07-25

Pages

201-3

Language

English

Region

England

NLM ID

0372673

PMCID

PMC1701141

Subset

External Links

PubMed source DOI: 10.1136/bmj.3.5716.201 PMC Full Text

Analysis Services

Trimethoprim-sulphamethoxazole in acute osteomyelitis due to penicillin-resistant staphylococci in Uganda.

Contact

WeChat Official Account